Latest Breaking News On - Ole onco se0009414576 - Page 1 : vimarsana.com

Oncopeptides AB , a biotech company focused on difficult-to-treat cancers, today announced that Holger Lembrer, Chief Financial Officer has decided to leave Oncopeptides to pursue a new role in. | June 15, 2023

United kingdomHolger lembrerRolf gulliksenMonica shawEuropean unionNasdaq stockholmChief financial officerPeptide drug candidateMarketing authorizationSmall capNews publishingOncopeptides ab publ stock exchangePress releaseOle onco se0009414576